Sigma Planning Corp Novavax Inc Transaction History

Sigma Planning Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$69.73 - $142.9 $117,495 - $240,786	-1,685 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$134.56 - $217.97 $47,768 - $77,379	355 Added 26.69%	1,685 $241,000
Q3 2021 Oct 28, 2021	BUY	$177.8 - $270.58 $19,558 - $29,763	110 Added 9.02%	1,330 $276,000
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $147,620 - $314,357	1,220 New	1,220 $259,000
Q1 2021 May 06, 2021	SELL	$112.98 - $319.93 $289,115 - $818,700	-2,559 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$78.74 - $139.5 $48,818 - $86,490	620 Added 31.98%	2,559 $285,000
Q3 2020 Nov 03, 2020	SELL	$79.44 - $178.51 $62,042 - $139,416	-781 Reduced 28.71%	1,939 $210,000
Q2 2020 Jul 31, 2020	BUY	$13.86 - $83.61 $37,699 - $227,419	2,720 New	2,720 $227,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.